Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

cell and gene therapy

This page shows the latest cell and gene therapy news and features for those working in and with pharma, biotech and healthcare.

Sartorius signs agreement to acquire Polyplus for €2.4bn

Sartorius signs agreement to acquire Polyplus for €2.4bn

Sartorius has said it will acquire Polyplus for around 2.4bn from private investors to bolster its activities supplying cell and gene therapy companies. ... for cell and gene therapy developers.

Latest news

More from news
Approximately 41 fully matching, plus 57 partially matching documents found.

Latest Intelligence

  • Meeting healthcare’s rising challenges Meeting healthcare’s rising challenges

    which time 80% of older people will be living in low- and middle-income countries. ... The promise is appealing, with a McKinsey report forecasting that healthcare innovations – from digital tools to gene and cell therapy – could reduce the total

  • CAR-T cell therapy in oncology CAR-T cell therapy in oncology

    In working with oncology CAR-T therapies, the stakes for an efficient cell and gene therapy (CGT) supply chain are especially high because recipients are often in the later stages of ... Brian Huber is Vice President, Drug Development and Tamie Joeckel

  • Building a brighter future with patient support programmes Building a brighter future with patient support programmes

    The high-rise promise of cell and gene therapy is the new architecture, gleaming with patient-centric potential and transformative intent. ... Collaborating does lead to greater things and it is exciting to see what developments in cell and gene therapy

  • Listen, learn and lift off Listen, learn and lift off

    The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are expecting a busy year for approvals, with frantic activity in orphan diseases as gene and cell therapy ... Mead still believes HCPs will demand data and learning from

  • Keeping up with the developing regulatory requirements for gene and cell therapies Keeping up with the developing regulatory requirements for gene and cell therapies

    A crucial challenge faced by cell and gene therapy developers is the necessity to balance clinical considerations with logistical ones such as manufacturing. ... That’s why developers have started exploring other techniques, for example using a

More from intelligence
Approximately 2 fully matching, plus 19 partially matching documents found.

Latest appointments

  • Health comms agency emotive hires new cell and gene therapy leader Health comms agency emotive hires new cell and gene therapy leader

    Dr Germano Ferrari. His most recent role was as a programme manager at the UK’s Cell and Gene Therapy Catapult where he helped develop commercialisation pathways for several pre-clinical ... Dr Ferrari said “We have now reached a turning point where

  • Weekly industry appointments Weekly industry appointments

    GSK’s CSO cell and gene therapy heads for the exit, Gelesis adds to company, Abcam appoints Peter Allen and Joseph Swedish joins Mesoblast’s board. ... be a global leader in the development and commercialisation of cell and gene therapy treatments.”

  • Orchard Therapeutics appoints Mark Rothera as CEO Orchard Therapeutics appoints Mark Rothera as CEO

    He said: “Now is an exciting time to be joining Orchard as the cell and gene therapy field is advancing successfully. ... The clinical data we’ve seen to date with Orchard’s therapy for ADA-SCID is exceptional, and the company has assembled and

  • Avita Medical appoints CEO Avita Medical appoints CEO

    chief scientific officer, global business development and licensing, and chief scientific officer for its cell and gene therapy unit. ... and Genetic Therapy Inc. Lou Panaccio, chairman of Avita, said: “Mike’s expertise across the value chain in cell

  • apceth Biopharma appoints Dusan Kosijer as CFO apceth Biopharma appoints Dusan Kosijer as CFO

    He said: “I am excited and honoured to be able to contribute to the company that operates successfully for almost 10 years in the fast-moving field of cell and gene ... successful track record as one of the leading CDMOs for complex cell and gene

More from appointments
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 16 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Parkinson’s disease: past, present and future
Examining the history and complexities of Parkinson’s disease – one of the most prevalent neurodegenerative disorders that affects over 10 million people worldwide...
The 17th World Congress on Controversies in Neurology
This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
Archetypes: Rethinking go-to-market expectations to drive commercial success
In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...

Quick links